Rezultati pretraživanja
  1. 27. sij

    New hope for patients with primary type 1. Read the news on ERA-EDTA Website!

  2. 27. ruj 2013.

    Join us tomorrow as we walk for awareness 9:30am Saturday, September 28th.

  3. 7. sij

    Thrilled to share that we’ve closed our Series A at and are excited to push our lead program to the clinic! If you’re interested in engineering medicines at the interface of and the , feel free to reach out - we’re hiring!

  4. 9. sij

    Congrats to the team on this milestone! Also congrats on the progress announced today in advancing candidates into the pipeline for and . Need more clinical data, but the future of living medicines is looking bright

  5. 4. velj

    The first clinical sign of is often a , but initial presentations can vary. Patients with severe hyperoxaluria may have recurrent, infrequent or no kidney stones, yet still develop . Learn more:

  6. 10. sij

    We're pleased to announce today that we've initiated a rolling submission of a New Drug Application (NDA) to the for lumasiran, an investigational therapeutic for the treatment of primary type 1 (PH1).

  7. 18. ožu 2016.

    Enteric : an important cause of end-stage disease

  8. 31. sij
  9. 23. sij
  10. 19. pro 2019.

    People who may have the primary type 1 (PH1) and their families can talk to their doctor about Alnylam Act’s no-cost, third-party genetic testing & counseling programs. Alnylam Act may help accelerate or confirm a PH1 diagnosis.

  11. 14. pro 2019.

    Clinical features of genetically-confirmed patients with primary identified by clinical indication versus familial screening et al

  12. 4. stu 2019.

    The next PH1 of a Kind video has arrived! Watch as Asha and her grandmother from Egypt visit the doctor, and Asha learns about why frequent doctor visits are so important for people living with the PH1 (primary type 1). Co-developed w/

  13. 23. ruj 2019.
  14. 17. kol 2019.

    Wonderful straightforward study supporting further evaluation of LDH5 as a therapeutic target for hyperoxaluria. Congrats Emmanuel !

  15. 23. lip 2019.

    Thanks Kim & Julie for inviting me to conference. Fabulous community, great info & committed docs, HCPs & researchers! Happy 30th Anniversary!

  16. 26. tra 2019.

    Excited for UCSD to be a research site for studying kidney stones in patients with enteric . Enrolling soon for uriROX-2 Phase 3 trial for reloxaliase

  17. Act for celiac disease! If you are 18 years or older and have had kidney stones caused by your celiac disease, you may qualify for a new clinical research study.

  18. 24. ožu 2019.

    Hemolytic Uremic in an Infant with Primary Type II: An Unreported Clinical Association 👩‍⚕️ Elisabetta Valoti 📰

  19. 11. sij 2019.
    Role of pediatric nephrologists in the work-up and management of kidney stones - Rodriguez Cuellar et al, 2019, Pediatric Nephrology

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.